Fri, Dec 26, 2014, 9:11 AM EST - U.S. Markets open in 19 mins.


% | $
Quotes you view appear here for quick access.

Exide Technologies Message Board

investor.novice 2 posts  |  Last Activity: Oct 17, 2014 3:04 PM Member since: Aug 28, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Needle Free Solutions, LLC (Testimonials)

    by bucs90 Oct 16, 2014 9:16 PM
    investor.novice investor.novice Oct 17, 2014 3:04 PM Flag

    shows that testimonials written by the same person. possible that company edited them but smells bad and made up. don't edit them. they look authentic unedited as i suspect they look same as they were edited. i wonder if it allows to be localized, how could it be effcetive as a flu vaccine that needs to be working throughout the blood stream? selling contines as investors know of the dilution from 17 million to 97 million shares by a 29 year old company that has not produced a dime for investors.

  • investor.novice by investor.novice Oct 15, 2014 12:13 PM Flag

    The price bump to $0.40 on 100 shares is manipulation if you watch on level 2. The dilution to 97 million shares that they did will take a long time to bust through $0.40, it has been 29 years that Bioject has not produced anything for investors. Bioject does not own research or manufacturing anymore, no assets, no audited financial statements, no press releases on flu vaccine, we are again in flu season, so stop pump that you have doing for years and now that they have something on Ebola, something on this and that. Those distributorship arrangements if you look deeply are without legs, small digs. First make a sale in United States for the world to follow, otherwise this will soon be back to $0.03 and I am not writing this to buy more as that will be your next comment. Stop hallucinating.

0.0601Dec 24 12:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Gilead Sciences Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Spectrum Pharmaceuticals, Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST